The Mission Report

The FireRock Conference

October 28, 2014 - The Spring Mills Landmark Building, New York City

FireRock Capital’s annual micro-cap conference attracts hundreds of high-net-worth investors and financial leaders. Featuring the “Who’s who” of the micro-cap investment world, this full day conference will have panels comprised of top deal makers as well as the leadership of FireRock’s portfolio company. The conference will be taking place at the Spring Mills Landmark Building in New York City. For more information on FireRock Capital and its conference, visit www.thefirerockconference.com.

AVT, Inc. (AVTC)

AVT, Inc. (OTC: AVTC) has been building vending machines and providing innovative solutions to the worldwide market for many years. As an industry leader, the company provides a full line of customized vending solutions, loaded with all the latest features. AVT offers methods of integrating vending into today’s cashless society, with advanced equipment, reporting and support. For more information, visit www.autoretail.com.

Cell Source, Inc. (CLCS)

Cell Source, Inc. (OTCQB: CLCS) is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented "Veto-Cell" technology addresses one of the most fundamental challenges in human immunology: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats. For more information, visit www.cell-source.com.

Cleveland BioLabs, Inc. (CBLI)

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant unmet medical need. The company’s programs are focused on the implementation of novel pharmacological approaches to control cell death. Its proprietary drug candidates act via unique mechanisms and targets to kill cancer and protect healthy cells. For more information, visit www.cbiolabs.com.

Cleveland BioLabs, Inc. (CLCN)

Creative Learning Corp. (OTCQB: CLCN) is the owner and developer of a unique and highly successful franchised children’s activity program called Bricks 4 Kidz®. The program is based on the operation of after-school classes in preschools, elementary schools and middle schools, in-school field trips, camps, birthday parties and other activities using the extremely popular LEGO® bricks as the basis for hands-on activities where students design and build interesting and challenging projects. For more information, visit www.creativelearningcorp.com.

DelMar Pharmaceuticals, Inc. (DMPI)

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) is focused on the development and commercialization of proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The company's lead asset, VAL-083, is currently undergoing clinical trials in the U.S. as a potential treatment for refractory glioblastoma multiforme, the most common and aggressive form of brain cancer. VAL-083 is currently approved for the treatment of chronic myelogenous leukemia and lung cancer in China. For more information, visit www.del-marpharma.com.

Gilla, Inc. (GLLA)

Gilla, Inc. (OTCQB: GLLA) designs, markets and distributes electronic cigarettes, vaporizers, e-liquids and related accessories. The company operates a two-pronged business model that focuses on white-label solutions, including branding, marketing and sales support; and e-commerce solutions such as Charlie's Club, a members-only online e-cigarette monthly subscription service featuring free hardware and no contracts. E-cigarettes and vaporizers are replacements for traditional cigarettes allowing smokers - they do not burn tobacco and are not smoking cessation devices. For more information visit www.gillainc.com.

LabStyle Innovations Corp. (DRIO)

LabStyle Innovations Corp. (OTCQB: DRIO) is changing the way people manage their chronic diseases. The company develops and commercializes patent-pending technologies that provide consumers with laboratory-testing capabilities using smart mobile devices. LabStyle’s flagship product is Dario™, the world’s first personalized smart meter to combine an all-in-one glucose meter that plugs directly into a smart mobile device with personalized information and community support. For more information, visit www.mydario.com.

ForceField Energy, Inc. (FNRG)

ForceField Energy, Inc. (NASDAQ: FNRG) is an international manufacturer, distributor and licensee of alternative energy products and solutions focused on the rapidly expanding multi-billion dollar renewable energy market. Additionally, the company is a worldwide distributor of high quality LED lighting with a leading LED manufacturer holding a number of patents, is a distributor of smart electric meters and has a subsidiary with a proprietary cutting edge technology that converts waste heat into clean electricity. For more information, visit www.forcefieldenergy.com.

MagneGas Corp. (MNGA)

MagneGas Corp. (NASDAQ: MNGA) is a technology company that has invented a patented process that converts liquid waste into hydrogen based fuels. The company currently sells MagneGas® into the metal working market as a replacement to acetylene. It is also selling equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets. In addition, the company is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications. For more information, visit www.MagneGas.com.

MELA Sciences, Inc. (MELA)

MELA Sciences, Inc. (NASDAQ: MELA) is a medical technology company dedicated to designing and developing innovative software-driven technologies that assist physicians during the clinical evaluation and detection of skin cancer. The company conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for its flagship product, MelaFind(R). For more information, visit www.melasciences.com.

Milestone Scientific Inc. (MLSS)

Milestone Scientific Inc. (OTCQB: MLSS) has developed epidural and intra-articular drug delivery systems based on a patented, painless, computer-controlled injection and drug delivery technology originally developed by Milestone Scientific, Inc. Development of both the epidural and intra-articular injection systems is now complete and the company is currently pursuing regulatory approval for both injection systems in the U.S. and European Union. For more information please visit www.medicalmilestone.com.

NXT-ID, Inc. (NXTD)

NXT-ID, Inc. (NASDAQ: NXTD) is focused on the growing m-commerce market, launching its innovative MobileBio® suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, with no smartphone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. For more information, visit www.wocketwallet.com.

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals (NASDAQ: ORMP) is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed's Protein Oral Delivery (POD™) technology is based on over 30 years of research by top scientists at Jerusalem's Hadassah Medical Center. The company is seeking to first revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801). For more information, visit www.oramed.com.

Pulse Evolution Corp. (PLFX)

Pulse Evolution Corp. (OTCQB: PLFX) is a digital production and IP company established to produce specialized, high-impact applications of computer-generated human likeness for utilization in entertainment, life sciences, education and telecommunication. Headquartered in Port St. Lucie, Florida, Pulse Evolution develops photorealistic digital humans, or "virtual humans," for live and holographic concerts, advertising, feature films, branded content, medical applications and training. For more information, visit www.pulse.co.

Symbid Corp. (SBID)

Symbid Corp. (OTCQB: SBID) provides a unique legal-financial structure that allows non-accredited investors to invest online in start-ups and growing companies for as little as $27 (EUR20). The company has emerged as a global leader in equity crowdfunding due to its innovative technological infrastructure, user-friendly interface and commitment to providing a secure funding environment for both investors and entrepreneurs. For more information, visit www.symbidcorp.com.

Validian Corp. (VLDI)

Validian Corp. (OTCQB: VLDI) is the leader in cyber security technology that provides secure access, retrieval, transfer, receipt and storage of digital information on wired, wireless and mobile devices and networks over the Internet. Validian technology enables the next generation of secure Mobile Messaging and Communications, Cloud Computing, Cloud Storage, Distributed Computing and Web Application and WebPortal Access and Usage for desktop & laptop computers, servers, tablets and SmartPhones. For more information, visit www.validian.com.

WOWIO, Inc. (WWIO)

WOWIO, Inc. (OTC: WWIO) is a technology development company with a patented process and a proprietary mobile ad-delivery platform that is designed to disrupt the eBook distribution landscape by exploiting a previously untapped marketplace: ad-supported eBooks. Exclusive ownership of an issued patent that governs this opportunity allows the company to expand its reach as a digital media company far beyond producing and distributing content across multiple platforms. For more information, visit www.studiowdigital.com.

 
Twitter

For more frequent updates, follow us on Twitter!

Home     About Us     IR Services     Investors     Partners     Market Research     Blog     Contact     Disclaimer

© 2014 Mission Investor Relations. All rights reserved.
3645 Marketplace Blvd.   Suite 130-280   Atlanta, GA 30344   404-941-8975